Yamamoto M, Tanaka Y, Takada R, Nakamoto A, Nakamoto M, Yagita H, Sakai T. (2024) Soy isoflavone genistein attenuates the efficacy of immune-checkpoint therapy in C57BL/6 mice inoculated with B16F1 melanoma and a high PD-L1 expression level reflects tumor resistance. J Clin Biochem Nutr 74:57-62.
Tanaka Y, Yamamoto M, Ohhashi H, Nakamoto A, Nakamoto M, Sakai T. (2024) The soy isoflavone genistein enhances IFN-g-induced PD-L1 expression in B16F1 melanoma cells in vitro. BPB reports7:21-25.
